| Dexamethasone in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 384 (8), 693-704, 2021 | 2827 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1524 | 2021 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1466 | 2020 |
| Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ... The Lancet 396 (10259), 1345-1352, 2020 | 803 | 2020 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 597* | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group Lancet (London, England) 399 (10320), 143, 2022 | 494* | 2022 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10289), 2049, 2021 | 420 | 2021 |
| Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized … GD Perkins, C Ji, BA Connolly, K Couper, R Lall, JK Baillie, JM Bradley, ... Jama 327 (6), 546-558, 2022 | 324 | 2022 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 319 | 2022 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 317* | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 238 | 2022 |
| Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021 | 147 | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ... The Lancet 397 (10274), 605-612, 2021 | 123 | 2021 |
| The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease D Adeloye, O Elneima, L Daines, K Poinasamy, JK Quint, S Walker, ... The Lancet Respiratory Medicine 9 (12), 1467-1478, 2021 | 107 | 2021 |
| COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD H McAuley, K Hadley, O Elneima, CE Brightling, RA Evans, MC Steiner, ... ERJ Open Research 7 (1), 2021 | 79 | 2021 |
| Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD post–COVID-19 study I Stewart, J Jacob, PM George, PL Molyneaux, JC Porter, RJ Allen, ... American journal of respiratory and critical care medicine 207 (6), 693-703, 2023 | 76 | 2023 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 75 | 2023 |
| Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization M Taquet, Z Skorniewska, A Hampshire, JD Chalmers, LP Ho, A Horsley, ... Nature medicine 29 (10), 2498-2508, 2023 | 47 | 2023 |
| Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis B Zheng, L Daines, Q Han, JR Hurst, P Pfeffer, M Shankar-Hari, ... European Respiratory Review 31 (166), 2022 | 40 | 2022 |
| Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19 L Houchen-Wolloff, K Poinasamy, K Holmes, M Tarpey, C Hastie, ... Thorax 77 (7), 717-720, 2022 | 25 | 2022 |
christopher brightlingProfessor Respiratory Medicine, University of Leicester在 leicester.ac.uk 的电子邮件经过验证
